The Rheumatology market is a subset of the Drug Discovery industry, focusing on the development of treatments for rheumatic diseases. These diseases are characterized by inflammation and pain in the joints, muscles, and other connective tissues. The market is driven by the need to develop new treatments for these conditions, as existing treatments are often inadequate. Companies in the market are researching and developing new drugs, biologics, and other therapies to address the unmet needs of patients. The Rheumatology market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, Pfizer, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
